INIS
diseases
100%
inflammation
100%
patients
46%
juveniles
20%
arthritis
20%
tumor necrosis factor
20%
comparative evaluations
13%
inhibition
13%
symptoms
13%
levels
6%
therapy
6%
risks
6%
pediatrics
6%
children
6%
surveys
6%
populations
6%
macrophages
6%
multivariate analysis
6%
Medicine and Dentistry
Inflammatory Bowel Disease
100%
Patient
40%
Combination Therapy
13%
Tumor Necrosis Factor
13%
Diagnosis
13%
Systemic Juvenile Idiopathic Arthritis
13%
Symptom
13%
Logistic Regression Analysis
6%
Juvenile Idiopathic Arthritis
6%
TNF Inhibitor
6%
Etanercept
6%
Family History
6%
Student T Test
6%
Fisher Exact Test
6%
Chi Square Test
6%
Macrophage Activation Syndrome
6%
Canakinumab
6%
Pediatrics
6%
Inpatient
6%
Incidence
6%
Child
6%
Medication
6%
Immunology and Microbiology
Inflammatory Bowel Disease
100%
Juvenile Idiopathic Arthritis
20%
Tumor Necrosis Factor Alpha
13%
Etanercept
6%
Electric Potential
6%
TNF Inhibitor
6%
Macrophage Activation Syndrome
6%
Canakinumab
6%
Incidence
6%
Biochemistry, Genetics and Molecular Biology
Tumor Necrosis Factors
13%
Electric Potential
6%
Chi-Square Testing
6%
Etanercept
6%
Pediatrics
6%
Incidence
6%